Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-M Michot

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 15, 2021
Severe COVID-19 in patients with hematological cancers presenting with viremiaJ M Michot, T Hueso, N Ibrahimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2021
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?A Laparra, M Kfoury, S Champiat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodiesM Collins, J M Michot, F X Danlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 31, 2015
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paperS Champiat, O Lambotte, E Barreau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewJ M Michot, C Bigenwald, S Champiat, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 15, 2021
Severe COVID-19 in patients with hematological cancers presenting with viremiaJ M Michot, T Hueso, N Ibrahimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2021
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?A Laparra, M Kfoury, S Champiat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodiesM Collins, J M Michot, F X Danlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 31, 2015
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paperS Champiat, O Lambotte, E Barreau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewJ M Michot, C Bigenwald, S Champiat, et al.
Pageof 4